Asia Pacific showed consistent and the fastest growth in Oncolytic Virus therapy trials in the past five years, exceeding 40% share in 2022.
Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023
Singapore - Novotech, the leading Asia Pacific centred biotech CRO with global e
Read more